Bart Molemans
- Nephrology top 2%
- Dialysis and Renal Disease Management 5
- Parathyroid Disorders and Treatments 1
-
- Erythropoietin and Anemia Treatment 3
-
- Vitamin D Research Studies 1
-
- Lipoproteins and Cardiovascular Health 2
-
- Biosimilars and Bioanalytical Methods 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
-
- Antiplatelet Therapy and Cardiovascular Diseases 1
- Co-authors
- Vicente TorregrosaHeikki SahaJ. BraunHans BrinkMartin WilkiePiergiorgio MessaWillem Jan W. BosDave Carter
- Journals
- Atherosclerosis (2 papers)Clinical Kidney Journal (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Bart Molemans
8 papers receiving 310 citations
Peers
Comparison fields: 5 of 49
- Nephrology 235
- Hematology 66
- Pathology and Forensic Medicine 82
- Nutrition and Dietetics 69
- Genetics 23
Countries citing papers authored by Bart Molemans
This map shows the geographic impact of Bart Molemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Molemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Molemans more than expected).
Fields of papers citing papers by Bart Molemans
This network shows the impact of papers produced by Bart Molemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Molemans. The network helps show where Bart Molemans may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart Molemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 57 | |
| 2 | 2020 | 1 | |
| 3 | 2011 | 1 | |
| 4 | 2010 | 21 | |
| 5 | 2010 | 54 | |
| 6 | 2009 | 16 | |
| 7 | 2008 | 170 | |
| 8 | Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism | 2006 | 4 |
About Bart Molemans
Bart Molemans is a scholar working on Nephrology, Hematology, Clinical Biochemistry, Emergency Medical Services and Biochemistry, having authored 8 papers that have together received 324 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), Erythropoietin and Anemia Treatment (3 papers), Lipoproteins and Cardiovascular Health (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Vitamin D Research Studies (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Nephrology (235 citations), Hematology (66 citations), Pathology and Forensic Medicine (82 citations), Nutrition and Dietetics (69 citations) and Genetics (23 citations). Bart Molemans has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Vicente Torregrosa, Heikki Saha, J. Braun, Hans Brink, Martin Wilkie, Piergiorgio Messa, Willem Jan W. Bos, Dave Carter, Francesco Locatelli and Helmut Graf. Their work appears in journals such as Atherosclerosis, Clinical Kidney Journal, Clinical Journal of the American Society of Nephrology, Journal of the American Society of Nephrology and Nephron Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.